These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Genetic variation in apolipoprotein E alters regional gray matter volumes in remitted late-onset depression. Yuan Y; Zhang Z; Bai F; You J; Yu H; Shi Y; Liu W J Affect Disord; 2010 Mar; 121(3):273-7. PubMed ID: 19647324 [TBL] [Abstract][Full Text] [Related]
4. Effects of ApoE-epsilon4 allele load and age on the rates of grey matter and hippocampal volumes loss in a longitudinal cohort of 1186 healthy elderly persons. Crivello F; Lemaître H; Dufouil C; Grassiot B; Delcroix N; Tzourio-Mazoyer N; Tzourio C; Mazoyer B Neuroimage; 2010 Nov; 53(3):1064-9. PubMed ID: 20060049 [TBL] [Abstract][Full Text] [Related]
5. Reduced hippocampal volume in non-demented carriers of the apolipoprotein E epsilon4: relation to chronological age and recognition memory. Lind J; Larsson A; Persson J; Ingvar M; Nilsson LG; Bäckman L; Adolfsson R; Cruts M; Sleegers K; Van Broeckhoven C; Nyberg L Neurosci Lett; 2006 Mar; 396(1):23-7. PubMed ID: 16406347 [TBL] [Abstract][Full Text] [Related]
7. Effect of APOE ε4 allele on cortical thicknesses and volumes: the AddNeuroMed study. Liu Y; Paajanen T; Westman E; Wahlund LO; Simmons A; Tunnard C; Sobow T; Proitsi P; Powell J; Mecocci P; Tsolaki M; Vellas B; Muehlboeck S; Evans A; Spenger C; Lovestone S; Soininen H; J Alzheimers Dis; 2010; 21(3):947-66. PubMed ID: 20693633 [TBL] [Abstract][Full Text] [Related]
8. Altered brain white matter integrity in healthy carriers of the APOE epsilon4 allele: a risk for AD? Persson J; Lind J; Larsson A; Ingvar M; Cruts M; Van Broeckhoven C; Adolfsson R; Nilsson LG; Nyberg L Neurology; 2006 Apr; 66(7):1029-33. PubMed ID: 16606914 [TBL] [Abstract][Full Text] [Related]
9. Apolipoprotein E epsilon4 is associated with atrophy of the amygdala in Alzheimer's disease. Basso M; Gelernter J; Yang J; MacAvoy MG; Varma P; Bronen RA; van Dyck CH Neurobiol Aging; 2006 Oct; 27(10):1416-24. PubMed ID: 16182410 [TBL] [Abstract][Full Text] [Related]
10. Cognitive domain decline in healthy apolipoprotein E epsilon4 homozygotes before the diagnosis of mild cognitive impairment. Caselli RJ; Reiman EM; Locke DE; Hutton ML; Hentz JG; Hoffman-Snyder C; Woodruff BK; Alexander GE; Osborne D Arch Neurol; 2007 Sep; 64(9):1306-11. PubMed ID: 17846270 [TBL] [Abstract][Full Text] [Related]
11. APOE and modulation of Alzheimer's and frontotemporal dementia. Boccardi M; Sabattoli F; Testa C; Beltramello A; Soininen H; Frisoni GB Neurosci Lett; 2004 Feb; 356(3):167-70. PubMed ID: 15036621 [TBL] [Abstract][Full Text] [Related]
12. [Brain volumetric MRI study in healthy elderly persons using statistical parametric mapping]. Miyahira Y; Yu J; Hiramatsu K; Shimazaki Y; Takeda Y Seishin Shinkeigaku Zasshi; 2004; 106(2):138-51. PubMed ID: 15052785 [TBL] [Abstract][Full Text] [Related]
13. Double-blind crossover study of the cognitive effects of lorazepam in healthy apolipoprotein E (APOE)-epsilon4 carriers. Stonnington CM; Snyder PJ; Hentz JG; Reiman EM; Caselli RJ J Clin Psychiatry; 2009 Oct; 70(10):1379-84. PubMed ID: 19573495 [TBL] [Abstract][Full Text] [Related]
14. Apolipoprotein E epsilon 4 allele is associated with increased atrophy in progressive mild cognitive impairment: a voxel-based morphometric study. Hämäläinen A; Grau-Olivares M; Tervo S; Niskanen E; Pennanen C; Huuskonen J; Kivipelto M; Hänninen T; Tapiola M; Vanhanen M; Hallikainen M; Helkala EL; Nissinen A; Vanninen RL; Soininen H Neurodegener Dis; 2008; 5(3-4):186-9. PubMed ID: 18322386 [TBL] [Abstract][Full Text] [Related]
15. Orbitofrontal cortex volume in late life depression: influence of hyperintense lesions and genetic polymorphisms. Taylor WD; Macfall JR; Payne ME; McQuoid DR; Steffens DC; Provenzale JM; Krishnan KR Psychol Med; 2007 Dec; 37(12):1763-73. PubMed ID: 17335636 [TBL] [Abstract][Full Text] [Related]
16. Reduced functional brain activity response in cognitively intact apolipoprotein E epsilon4 carriers. Lind J; Persson J; Ingvar M; Larsson A; Cruts M; Van Broeckhoven C; Adolfsson R; Bäckman L; Nilsson LG; Petersson KM; Nyberg L Brain; 2006 May; 129(Pt 5):1240-8. PubMed ID: 16537568 [TBL] [Abstract][Full Text] [Related]
17. APOE4 is associated with greater atrophy of the hippocampal formation in Alzheimer's disease. Pievani M; Galluzzi S; Thompson PM; Rasser PE; Bonetti M; Frisoni GB Neuroimage; 2011 Apr; 55(3):909-19. PubMed ID: 21224004 [TBL] [Abstract][Full Text] [Related]
18. Synergistic effect of apolipoprotein E epsilon4 and butyrylcholinesterase K-variant on progression from mild cognitive impairment to Alzheimer's disease. Lane R; Feldman HH; Meyer J; He Y; Ferris SH; Nordberg A; Darreh-Shori T; Soininen H; Pirttilä T; Farlow MR; Sfikas N; Ballard C; Greig NH Pharmacogenet Genomics; 2008 Apr; 18(4):289-98. PubMed ID: 18334913 [TBL] [Abstract][Full Text] [Related]
19. Influence of apolipoprotein E epsilon4 genotype on brain tissue integrity in relapsing-remitting multiple sclerosis. De Stefano N; Bartolozzi ML; Nacmias B; Zipoli V; Mortilla M; Guidi L; Siracusa G; Sorbi S; Federico A; Amato MP Arch Neurol; 2004 Apr; 61(4):536-40. PubMed ID: 15096402 [TBL] [Abstract][Full Text] [Related]
20. Medial temporal lobe dysfunction during encoding and retrieval of episodic memory in non-demented APOE epsilon4 carriers. Kukolja J; Thiel CM; Eggermann T; Zerres K; Fink GR Neuroscience; 2010 Jun; 168(2):487-97. PubMed ID: 20350587 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]